Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach
Bisphosphonates are commonly prescribed to inhibit bone loss in patients with osteoporosis, as well as osteopenia, cancer, and Paget's disease of the bone. Recently, scientific literature has addressed a possible relationship between bisphosphonates and osteonecrosis of the jaw (ONJ). It is imp...
|Corporate Author:||SpringerLink (Online service)|
|Other Authors:||De Ponte, Francesco Saverio.|
No Tags, Be the first to tag this record!